Johnson Financial Group Inc. decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 38.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,881 shares of the healthcare conglomerate’s stock after selling 11,628 shares during the quarter. Johnson Financial Group Inc.’s holdings in UnitedHealth Group were worth $3,501,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors also recently added to or reduced their stakes in UNH. Marshall Wace LLP increased its holdings in shares of UnitedHealth Group by 441.4% in the second quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after acquiring an additional 11,361 shares in the last quarter. Schwab Charles Investment Management Inc. increased its holdings in shares of UnitedHealth Group by 5.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after acquiring an additional 183,401 shares in the last quarter. American Century Companies Inc. increased its holdings in shares of UnitedHealth Group by 16.9% in the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after acquiring an additional 681,111 shares in the last quarter. Essex Financial Services Inc. increased its holdings in shares of UnitedHealth Group by 12.3% in the second quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after acquiring an additional 967 shares in the last quarter. Finally, Factory Mutual Insurance Co. increased its holdings in shares of UnitedHealth Group by 20.9% in the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock worth $77,245,000 after acquiring an additional 72,000 shares in the last quarter. 86.00% of the stock is currently owned by hedge funds and other institutional investors.
Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at $211.71 on Wednesday. The stock has a market capitalization of $204,541.08, a P/E ratio of 21.99, a PEG ratio of 1.57 and a beta of 0.64. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group Incorporated has a 52-week low of $148.56 and a 52-week high of $213.93.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the firm posted $2.17 EPS. sell-side analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be issued a dividend of $0.75 per share. The ex-dividend date is Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.42%. UnitedHealth Group’s payout ratio is currently 33.26%.
Several equities research analysts have issued reports on the company. Barclays PLC increased their price target on UnitedHealth Group from $200.00 to $217.00 and gave the stock an “overweight” rating in a report on Wednesday, July 19th. Leerink Swann restated a “buy” rating and issued a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price target for the company in a report on Thursday, September 21st. Cantor Fitzgerald increased their price objective on UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. Finally, Oppenheimer Holdings, Inc. increased their price objective on UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a report on Wednesday, October 18th. Three equities research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $216.65.
In related news, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the sale, the director now directly owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Over the last three months, insiders have sold 72,149 shares of company stock valued at $14,212,342. 0.89% of the stock is currently owned by insiders.
TRADEMARK VIOLATION NOTICE: “Johnson Financial Group Inc. Has $3.50 Million Holdings in UnitedHealth Group Incorporated (UNH)” was published by Transcript Daily and is the property of of Transcript Daily. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://transcriptdaily.com/2017/11/15/johnson-financial-group-inc-has-3-50-million-holdings-in-unitedhealth-group-incorporated-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.